Blue Jet Healthcare Limited engages in the manufacturing and sale of artificial sweeteners, pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in products. It provides contrast media intermediates, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures...
Blue Jet Healthcare reported revenue of 10.30 billion INR for fiscal year 2025, up 44.7% from fiscal year 2024, and net income of 3.05 billion INR. In Q1 2026 (the quarter ended June 30, 2025) revenue was 3.55 billion INR, up 117.8% from a year before. France was its largest region in fiscal year 2025, with 42% of revenue. Its market capitalization was 90.01 billion INR as of October 12, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 12, 2026.
No profile data available.